Evidence map›Paper›PMID 30651301›Full record

ArticleThe Journal of cell biology2019

Saccharopine, a lysine degradation intermediate, is a mitochondrial toxin.

João Leandro, Sander M Houten

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Alternating High-Fat and Polysaccharide Diets Modulates Gut Phage-Bacterial Interplay.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Review
  6. In Vitro Cytotoxic Activity ofMolecules (Basel, Switzerland) · 2026
    Article
  7. Article
  8. LysineFrontiers in molecular neuroscience · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

João LeandroDepartment of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY.
Sander M HoutenDepartment of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY sander.houten@mssm.edu.ORCID 0000-0002-6167-9147
Icahn School of Medicine at Mount Sinai · US

Funding

Novel Treatment Options for Glutaric AciduriaR21HD088775 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DEVITA, ROBERT J, HOUTEN, SANDER MICHEL · 2017 to 2018
$466k
Genetic validation of DHTKD1 as a therapeutic target for the treatment of Glutaric Aciduria type 1R03HD092878 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HOUTEN, SANDER MICHEL · 2017 to 2018
$170k
NICHD NIH HHS R03 HD092878NICHD NIH HHS R21 HD088775
6 · The paper itself

Abstract

Saccharopine, a nonproteinogenic amino acid originally isolated from the yeast

Indexed as

LysineSaccharomyces cerevisiaeAnimalsHomeostasisMiceMitochondriaLysinesaccharopine

Identifiers

PMID30651301
PMCPMC6363453
OpenAlexW2910309975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.